One study showed expression of PPAR-γ in pancreatic cancer is correlated with shorter patient survival [171], while expression of PPAR-γ in colon adenocarcinoma samples corresponded to increased expression of cell-cycle molecules [129]. This evidence concerns the gene PPARG and familial pancreatic carcinoma.